Blockchain Registration Transaction Record

Silo Pharma Files Patent for Intranasal Compound SPC-14 Targeting Alzheimer’s Symptoms

Silo Pharma announces the filing of a patent application for SPC-14, a novel intranasal compound targeting Alzheimer’s symptoms. Learn more about Silo Pharma's innovative approach to developing therapeutics for underserved conditions.

Silo Pharma Files Patent for Intranasal Compound SPC-14 Targeting Alzheimer’s Symptoms

This news matters as it highlights Silo Pharma's innovative approach in developing novel therapeutics for underserved conditions like Alzheimer's disease. The filing of the patent for SPC-14 signifies a significant step towards addressing cognitive and neuropsychiatric symptoms in Alzheimer’s patients, potentially offering hope for improved treatment options in the future.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xcbb35da66fda15375824d3de57fef4592bde7c7001b9fe461a0e45edcb98004b
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprinttileKuCf-ff8ce5290d447cb6ae2c3645db661d71